The Department of Biotechnology( DBT), through Indian Society of Nanomedicine, has formulated the draft “Guidelines for evaluation of nanopharmaceuticals in India” after series of consultations with the stakeholders. The department had organized an inter-ministerial meeting recently and the draft guidelines have been further revised.

 

Click here to download Proposed Guidelines

http://www.dbtindia.nic.in/wp-content/uploads/Modified-Guidelines-for-Evaluation-of-Nanopharmaceuticals-in-India-converted-2.pdf

The comments/ observations pertaining to the same may be conveyed by March 12, 2019 to coo@ableindia.org.in / nanobiotech.dbt@nic.in

Institutions, industry, and researchers engaged in research & development in Nanobiotechnology have been reached by the Department of Biotechnology to seek comments on “Guidelines for evaluation of nanopharmaceuticals in India”.